Healthcare professionals are involved in the detection, monitoring, management and treatment of chronic disease conditions and diabetes. The American Diabetic Association has stated that early detection is critical to improving the outcome.



In the U.S. there are about 25.8 million people with diabetes and another estimated 79 million with pre-diabetes. "The Centers for Disease Control and Prevention (CDC) has declared diabetes at epidemic levels in the United States. The CDC estimates 90% of those with pre-diabetes don’t know they have the condition." The World Health Organization estimates 220 million people live with diabetes worldwide today and will more than double by 2030.

In early 2013 Freedom Meditech received FDA clearance for the first-in-class CLEARPATH DS-120™ device that detects autofluorescence of the crystalline lens of the eye.  In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products, which accumulate in the presence of diabetes and uncontrolled glucose over time.